An Instrument to Assess Patient Perceptions of Satisfaction With Acute Migraine Treatment (EXPERT Study)
Headache: The Journal of Head and Face Pain, 04/19/2011LanteriMinet M et al. –
The new instrument should allow easy identification in general practice of the patients receiving an effective or ineffective acute treatment of migraine and thus facilitate the implementation of treatment guidelines for migraine.
A total of 2108 GPs included 11,274 migraine patients
Satisfaction with treatment was evaluated using a 4–point verbal scale and a 10–cm visual analog scale (VAS)
Treatment effectiveness was assessed by the 4–item questionnaire designed by the French Medico–Economic Evaluation Service (ANAES) and the French Society for the Study of Migraine Headache (SFEMC)
In total, 5224 patients (49.8%) stated that they were satisfied with their treatment
Mean VAS score was 5.1. Only 17% of patients (1789/10,539) gave positive responses at the 4 questions of the ANAES/SFEMC questionnaire
VAS score was high for patients satisfied with their treatment and with good treatment effectiveness
Two VAS thresholds were determined using receiver operating characteristic curves that allowed easy identification, with high sensitivity and specificity, of patients satisfied/dissatisfied with their current treatment and with good/poor treatment effectiveness
Based on EXPERT data, this instrument showed that only 16% of patients using triptans (597/3719) were dissatisfied and reported poor treatment effectiveness, whereas treatment was inadequate for 63% of those using aspirin or nonsteroidal anti–inflammatory drugs (1882/2992), 74% of those using paracetamol or other analgesics (2229/2998), and 53% of those using ergotamine (253/474)
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.